Reports

This report provides critical insights for professionals managing PFAS-related risks in products and supply chains, including chemical manufacturers, regulatory experts, R&D teams, and sustainability strategists. Backed by CAS’s expert-curated scientific data and structural analysis of over 350,000 PFAS compounds, it helps organizations navigate evolving global regulations and identify sustainable alternatives.

This report provides strategic insights into emerging lipid innovations, formulation techniques, clinical applications, and future directions driven by nanotechnology and personalized medicine. Drawing from over 200,000 scientific documents, the report offers a comprehensive analysis of lipid-based drug delivery technologies, highlighting their evolution from simple liposomes to advanced nanoparticles and their transformative impact on therapeutics across oncology, infectious diseases, and gene therapy.